Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-09 Sale |
2022-02-11 6:09 pm |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
221 | $36.3 | $8,022 | 96,961 (Direct) |
View |
| 2021-07-14 Sale |
2021-07-15 5:53 pm |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
1,869 | $74.9 | $139,988 | 21,767 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-09 Option Award |
2022-02-11 6:09 pm |
N/A 2032-02-08 |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
74,883 | $0 | 96,961 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 5:59 pm |
N/A 2031-02-07 |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
11,869 | $0 | 33,369 (Direct) |
View |
| 2020-07-13 Option Award |
2020-07-14 5:40 pm |
N/A 2030-07-12 |
Turning Point Therapeutics Inc. | TPTX | Partridge Andrew John EVP & Chief Commercial Officer |
149,000 | $0 | 149,000 (Direct) |
View |